Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC39H65N5O8 |
InChIKeyMFRNYXJJRJQHNW-DEMKXPNLSA-N |
CAS Registry745017-94-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - | |
Neoplasms | Discovery | US | - |